Health IT

Skin Analytics' DERM Zero is the first AI to get Class III certification for autonomous skin cancer checks on a smartphone, promising to transform access.

A recent Hong Kong summit unveiled a new frontier: tokenizing everyday consumption. Behind the buzz, a strategic play to build the rails for a new digital economy is underway.

Biotech firm Azitra is leveraging its engineered microbe tech to tackle rare diseases and enter the $71B cosmeceutical market. Is this a brilliant pivot or a risky bet?

A $1.2M seed round for orthopaedic AI firm Maia isn't just startup news. It signals a systemic shift from generalist AI to specialized digital engines.

A new Illinois wellness center combines FDA-cleared depression therapy with cosmetic treatments, raising critical questions about the future of healthcare delivery.

Australian healthtech Everlab secures a huge Series A to take its AI-driven preventative care platform global. Can it remake healthcare or will data and regulation stall it?

Health Canada issues a stark warning on illegal hyperbaric chambers in wellness centres, citing fatal risks. How did these devices bypass the path to profit?

A new report reveals substance use costs Canada's healthcare system $16.4B annually, with alcohol and tobacco driving 90% of the bill. It's not just addiction.

A new partnership between HCPro and ZHealth aims to solve the costly, error-prone challenge of specialty coding in radiology and cardiology. Here’s why.

A landmark court ruling forces a recall of Siemens' latest mammography tech, handing Hologic a major victory and sending shockwaves through Europe's MedTech.

As a rare Ebola strain rages in a DRC warzone, the G7 pledges massive aid. But with fragile peace deals and no proven cure, is it enough to stop a global crisis?

XREAL unveils AURA, lightweight XR glasses powered by Google and Qualcomm. Can this trinity of tech finally deliver on the promise of everyday spatial computing?

Medincell's latest results show a planned loss but reveal a strategic shift to recurring royalties, fueled by UZEDY®'s success and a pipeline set for growth.

Beyond a competition, China's medical AI initiative is a bold act of tech diplomacy, aiming to revolutionize diagnostics and build a new innovation hub.

Cincinnati Children's and Parkview Health finalize a landmark agreement, promising to reduce travel for families and reshape the regional healthcare market.

A new partnership aims to disrupt the opaque PBM industry. By pairing a transparent model with modern tech, it could finally lower your prescription costs.

A major merger backed by private equity signals a new era for pharmaceutical training, blending AI, behavioral science, and launch expertise to tackle industry complexity.

A new report shows Blue Cross Blue Shield plans have slashed administrative cost growth, a sign of rare efficiency. But what does this mean for your wallet?

With a novel non-hallucinogenic drug, Enveric Biosciences heads to the BIO convention seeking partners. Can its unique science secure its future?

The legendary wellness brand's new Austin resort isn't just a luxury getaway; it's a blueprint for integrated living, blending a hotel, homes, and a medical center.